Leontine Narcisse-Ogera, MD, PhD, is a seasoned and proven leader in scientific services and medical communications. As the senior vice president of scientific services at eNOVA, a company acquired by IQVIA, she plays a pivotal role in driving the company forward. Dr. Narcisse-Ogera ensures that eNOVA remains at the cutting edge of the pharmaceutical industry, managing the scientific department, setting performance standards, and overseeing the development of her team. She also connects eNOVA with IQVIA, serving as a vital link between the two organizations and their medical professionals.
Dr. Narcisse-Ogera began her academic pursuits with a Bachelor of Arts in Latin and pre-med from Columbia University, followed by a Doctor of Medicine and a Doctor of Philosophy in neuropathology from the Albert Einstein College of Medicine. Her postgraduate training includes a surgical residency at New York Methodist Hospital in 2008 and a fellowship in surgical critical care at Westchester Medical Center in 2009. Her extensive medical training, especially her advanced training in trauma care, has been invaluable.
Before joining eNOVA in 2022, Dr. Narcisse-Ogera held leadership positions across prominent medical communications and strategy firms. She was the executive director of scientific communications at Vaniam Group from 2020 to 2022, where she designed and implemented a writer training program. This program’s innovative approach included blind reviews of writing tests, leading to the hiring of a diverse group of 28 writers, including women, people of color, and older individuals seeking career changes. Many of these individuals have continued to thrive in the industry, and Dr. Narcisse-Ogera takes pride in following their progress. Building on her experience, Dr. Narcisse-Ogera was a senior scientific director and team leader at Alligent Group, part of Envision Pharma Group. She also held various positions at ProHealth, an IPG Health Company, including vice president and medical strategy director, senior medical director, and medical director. Additionally, she was the medical director at ClinicalMind and Health Science Communications.
Dr. Narcisse-Ogera credits much of her success to her clinical background. She reflects on her father’s advice during her time as a surgical resident: never say no to a case and learn from everyone in the operating room. This philosophy shaped her approach to medical communications, allowing her to gain confidence quickly and embrace challenges fearlessly. Working in high-stakes medical environments, particularly during trauma codes and emergencies, helped her develop a calm and level-headed demeanor, useful in navigating complex business scenarios. One of Dr. Narcisse-Ogera’s most significant career highlights occurred while she was an assistant medical director at her first job. She retained a multimillion-dollar account by acting as an internal customer, preventing a subsidiary company from leaving the organization. This proved her ability to think strategically and leverage her clinical insights to retain key business relationships.
r. Narcisse-Ogera finds inspiration in the team she manages. She values the varied experiences her colleagues bring from other agencies and fields, often finding motivation in their unique perspectives. She finds joy in collaborating with her colleagues to assist them in achieving their goals and considers this to be one of the most rewarding aspects of her job. A memorable moment in Dr. Narcisse-Ogera’s career involved her contribution to Merck’s Global Breast Cancer Team. She initially clashed with Merck’s global medical affairs director during a meeting. However, her expertise shifted the client’s perspective, leading the director to express gratitude for the insights she brought to the discussion. This interaction reinforced her belief in the impact she could have on her clients and their strategic decisions.
Currently, Dr. Narcisse-Ogera continues to push eNOVA to new heights. Her responsibilities include maintaining the company’s leadership position in scientific strategy, ensuring transparent and high-quality deliverables, and offering support following eNOVA’s acquisition by IQVIA. In the next three to five years, she aims to help her team adapt to these changes, establish a new division within the company, and clearly communicate eNOVA’s identity and value proposition to the acquiring company.
Dr. Narcisse-Ogera participates in civic engagements, including her work with Say Yes to Cancer. She is a member of the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), which keeps her connected to the latest oncology and scientific research developments. In her personal time, she enjoys knitting and weaving, hobbies that offer her a creative outlet. Her journey has been defined by the core values of continuous learning, a composed response to difficulties, and a steadfast focus on fostering her team’s growth and success. Her path reflects resilience, adaptability, and a deep passion for driving positive change in health care.
